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Objectives: Cross-resistance between antibiotics and biocides is a potentially important driver of MDR. A relation- 
ship between susceptibility of Salmonella to quinolones and triclosan has been observed. This study aimed to: 
(i)  investigate  the  mechanism  underpinning  this;  (ii)  determine  whether  the  phenotype  is  conserved  in 
Escherichia coli; and (iii) evaluate the potential for triclosan to select for quinolone resistance. 
Methods: WT E. coli, Salmonella enterica serovar Typhimurium and gyrA mutants were used. These were charac- 
terized by determining antimicrobial susceptibility, DNA gyrase activity and sensitivity to inhibition. Expression of 
stress response pathways (SOS, RpoS, RpoN and RpoH) was measured, as was the fitness of mutants. The poten- 
tial for triclosan to select for quinolone resistance was determined. 
Results: All gyrase mutants showed increased triclosan MICs and altered supercoiling activity. There was no evidence 
for direct interaction between triclosan and gyrase. Identical substitutions in GyrA had different impacts on supercoiling 
in the two species. For both, there was a correlation between altered supercoiling and expression of stress responses. 
This was more marked in E. coli, where an Asp87Gly GyrA mutant demonstrated greatly increased fitness in the pres- 
ence of triclosan. Exposure of parental strains to low concentrations of triclosan did not select for quinolone resistance. 
Conclusions: Our data suggest gyrA mutants are less susceptible to triclosan due to up-regulation of stress 
responses. The impact of gyrA mutation differs between E. coli and Salmonella. The impacts of gyrA mutation be- 
yond quinolone resistance have implications for the fitness and selection of gyrA mutants in the presence of 
non-quinolone  antimicrobials. 
 
 
Introduction 
Antimicrobials are crucial for the prevention and treatment of dis- 
eases but their efficacy is under threat due to bacterial drug resist- 
ance.1 Interactions between antibiotics of different classes have 
long been recognized and can be synergistic or antagonistic.2–4 
We and others have observed that there is an association between 
resistance to quinolone antibiotics resulting from topoisomerase 
mutation and susceptibility to the biocide triclosan, although a 
mechanistic basis to explain this link has not been described.5–9 
Mechanisms of antimicrobial resistance can be specific to single 
agents or can confer reduced susceptibility to multiple agents, 
including those  with  very  different  chemistry  and  targets.10  
In Gram-negative bacteria most quinolone antibiotics primarily 
target the essential topoisomerase  DNA gyrase. High levels     of 
 
resistance are conferred by multiple mutations within portions of 
the gyrA and parC genes known as the QRDR that reduce binding 
efficiency of the drug to the enzyme–DNA complex.11 Additional 
mutations in genes encoding other topoisomerase subunits, de- 
repression of multidrug efflux pumps and acquisition of mobile 
quinolone resistance genes are also contributors to quinolone 
resistance.11 
Triclosan is a biocide that has been commonly incorporated 
into a wide range of domestic products to provide antimicrobial ac- 
tivity. Unusually for a biocide, triclosan has a specific cellular target, 
the enzyme FabI, which catalyses an essential step in fatty acid 
biosynthesis. High-level resistance to triclosan is mediated by mu- 
tations in the fabI gene, resulting in a mutant protein that is not 
bound efficiently by triclosan.12,13 As for quinolones, resistance to 
 
 
  
 
Table 1.  Strains, GyrA substitutions and antimicrobial  susceptibility  
   MIC (mg/L)  
Strain GyrA genotype Relative supercoiling activitya Ciprofloxacin IC50 (lM) nalidixic acid ciprofloxacin triclosan 
E. coli 
MG1655 WT 100 
 
0.5 
 
8 
 
0.008 
 
0.06 
I980 Ser83Phe 90 7 512 0.06 0.25 
I1042 Asp87Gly 15 5 512 0.06 0.25 
 
Salmonella Typhimurium 
    
SL1344 WT 100 7 4 0.015 0.06 
L821 Ser83Phe 30 35 512 0.12 0.25 
L825 Asp87Gly 15 70 512 0.12 0.25 
aFor each enzyme activity is relative to the WT (100%). 
 
 
triclosan is multifactorial, with other mechanisms, including multi- 
drug efflux and changes to core metabolism, being shown to con- 
tribute.14–17 
Recently, we demonstrated that a quinolone-resistant mutant 
of Salmonella Typhimurium SL1344 (carrying a substitution within 
GyrA of Asp87Gly) exhibited a broad, low-level, decrease in suscep- 
tibility to various antimicrobials.5 The effect was seen for this 
mutant, but not for the more commonly observed Ser83Phe sub- 
stitution in the same background. Interestingly, both mutants 
were less susceptible to triclosan (MIC of triclosan 0.25 mg/L for 
both GyrA mutants compared with 0.06 mg/L for the parental 
strain) and this was the largest MIC change seen for any drug.5 
The decreased susceptibility to quinolones and triclosan was not a 
result of increased efflux in gyrA mutants.5 The link between quin- 
olone and triclosan resistance is important as triclosan has be- 
come ubiquitous in the environment, foodstuffs and even human 
All experiments were repeated on three occasions and each included two 
biological and two technical replicates per strain. Biolog phenotypic micro- 
arrays were used to determine differences in the ability of strains to respire 
in the presence of antimicrobials using plates PM11–20.29 
 
Enzymes and supercoiling assays 
Full-length gyrase subunits of each species were expressed and re- 
constituted for supercoiling assays. E. coli gyrase subunits, WT and mutant, 
were expressed in strains JMtacA (gyrA) and JMtacB (gyrB) and purified as 
described previously.30 Salmonella gyrase genes were amplified by PCR 
from SL1344 and mutant strains described previously5 and cloned into 
plasmid pET28a, which was transformed into E. coli BL21(DE3) pLysS. 
Cultures (10 mL) were grown, protein expression induced and proteins iso- 
lated as previously described.30 
Mutations were introduced into the GyrA expression plasmids using the 
QuikChangeV
R  
Site-Directed Mutagenesis Kit (Stratagene) according to the 
tissues in the last 20 years.18–24 If gyrA mutants have a competi- 
tive advantage over WT strains in the presence of triclosan, then 
triclosan found in the environment may promote the survival or 
emergence of quinolone-resistant mutants. Infection in people 
with quinolone-resistant Salmonella carries a significantly higher 
risk of mortality than infection with susceptible strains.25 
This study aimed to determine whether the impact of GyrA 
substitutions was similar in Escherichia coli and Salmonella.26 
Secondly, we aimed to investigate the mechanisms of cross- 
resistance between quinolones and triclosan. 
 
Methods 
Strains 
E. coli MG1655 and Salmonella Typhimurium SL1344 were used as WT 
strains (Table 1). gyrA mutants were as described previously.5,27 SL1344- 
derivative L1234 was used as a positive control in fluorescence experiments 
as previously described.28 
 
 
Antimicrobial susceptibility testing 
The MICs of antibiotics and triclosan were determined following the 
EUCAST-recommended agar dilution methodology. Differences in ability to 
grow in the presence of antimicrobials were determined by measuring 
absorbance over time in a FluoSTAR Optima plate reader (BMG Labtech).5 
manufacturer’s  instructions.  DNA  supercoiling  assays  with  E.  coli   and 
Salmonella gyrases were under conditions as described previously.31 
 
Competitive fitness assays 
The competitive fitness of gyrA mutants when co-cultured with their paren- 
tal strain was assessed as previously described.5 For each competition ex- 
periment, four separate cultures of parental and mutant strain were grown 
in 10 mL of LB broth at 37○C overnight. A viable count of each sample was 
determined and four competition lineages were established by introducing 
100 lL each of one parental and one mutant lineage into 10 mL of pre- 
warmed LB broth. A sample was taken at time 0 and diluted, and the viable 
count of both parent and mutant strain determined by plating samples on 
LB agar with or without 64 mg/L nalidixic acid. Each lineage was incubated 
and sampled at 12 h timepoints. After 12 h, 100 lL of each mixed culture 
was used to inoculate a fresh broth. This was repeated for seven passage 
cycles. At each timepoint the ratio of parent:mutant in each lineage was 
determined. Experiments were replicated in the presence and absence of 
0.03 mg/L triclosan. 
 
 
Selection of quinolone-resistant mutants by triclosan 
In order to determine whether triclosan would promote the emergence of 
gyrA mutants by exerting a selective pressure for these strains, an in vitro 
evolution experiment was used. E. coli MG1655 was repeatedly passaged in 
medium alone or in the presence of 0.03 mg/L triclosan. This concentration 
and E. coli were used as in competition  assays  containing  triclosan     the 
  
 
E. coli Asp87Gly mutant outcompeted its parent rapidly (more than    the 
Salmonella equivalent mutant). 
Six independent lineages of MG1655 were grown overnight as above. 
Each lineage (A–F) was divided into two 10 mL cultures by adding 100 lL 
of each overnight culture into fresh broth; half had no drug and half con- 
tained 0.03 mg/L triclosan. These were then grown at 37○C, with shaking 
at 200 rpm until stationary phase was reached. Samples were taken as in 
competition experiments and a sample of each lineage was added to new 
broth. The passaging was repeated 10 times. In each sample, numbers of 
quinolone-resistant mutants were determined as in competition assays 
and the frequency of nalidixic acid-resistant mutants was calculated. 
Twenty mutants recovered from either drug-free or triclosan-containing 
media experiments were randomly selected and the QRDR of gyrA was 
amplified and sequenced (all primers used are in Table S1, available as 
Supplementary data at JAC Online). 
 
Measurement of stress response gene expression 
In our previous publication we identified up-regulation of general stress re- 
sponse pathways in gyrase mutants.5 To monitor expression of these path- 
ways in each of the mutants under different conditions, reporter strains 
were made in plasmid pMW82.32 A series of promoters known to respond 
to these stresses were amplified by PCR and cloned upstream of gfp. The 
promoters were recA (SOS response), gabD (rpoS), glnA (rpoN) or odpA 
(rpoH); each was conserved in both species. The constructs were introduced 
into all strains of interest and the fluorescence emitted by each was meas- 
ured in various conditions. All assays were completed at 37○C in LB medium. 
Replicate experiments were completed with the addition of various stres- 
sors to act as controls for the relevant stress  responses:  nalidixic acid 
(80 mg/L, an SOS response inducer); serine hydroxymate (100 mg/L, a strin- 
gent response inducer of RpoS and RpoN); sucrose (20% final concentration, 
an inducer of RpoE); growth at 42○C (an inducer of RpoH); and chlorpromaz- 
ine (50 mg/L, an inducer of the ramA–gfp reporter as a control for measur- 
ing induction of fluorescence). 
Overnight cultures of each strain were diluted 1:100 in MOPS minimal 
medium (Teknova, USA) supplemented with 50 mg/L ampicillin. Cultures 
were incubated at 37○C until mid-log phase. Cells were then harvested by 
centrifugation and re-suspended in 500 lL of PBS before 200 lL of each 
was transferred into the wells of a microtitre tray. Fluorescence from GFP 
(excitation 492 nm, emission 520 nm) was then measured in two ways. 
Firstly, fluorescence was measured in a BMG FluoSTAR plate reader every 
10 min for 16 h (absorbance at 600 nm was also measured at each 
timepoint and fluorescence/absorbance values were then compared be- 
tween strains). Secondly, samples were also taken and analysed by flow 
cytometry to examine population dynamics by measuring expression from 
individual cells within a population. All experiments included three biolo- 
gical replicates of each strain in each condition. 
For flow cytometry, strain L1234 was used as a positive control.28 Data 
from this strain were used to set gates to identify GFP-producing cells. 
Samples were then run until 50000 cells within the GFP-producing popula- 
tion had been analysed. Flow cytometry used an Attune NxT instrument 
and software for data analysis (ThermoFisher, UK). 
 
Results 
Gyrase mutants of E. coli and Salmonella have reduced 
susceptibility to triclosan 
In both E. coli and Salmonella, substitutions at serine 83 and 
aspartic acid 87 of GyrA resulted in an 8-fold increase in ciprofloxa- 
cin MIC and between 64- and 128-fold increases in nalidixic acid 
MIC (Table 1). Both substitutions also increased the MIC of triclosan 
4-fold in both species. These results were supported by growth kin- 
etics and Biolog Phenotype Microarrays. In LB medium alone, there 
was no significant change in growth rate between the parental 
strains and their gyrase mutants (Figure S1). However, in the pres- 
ence of 0.03 mg/L triclosan (0.5% the MIC for the parental strains) 
both E. coli and Salmonella Asp87Gly mutants grew better than 
the Ser83Phe mutants or the parental strains. The Phenotype 
Microarray data for strains grown in the presence of nalidixic acid 
showed that both Salmonella gyrase mutants were able to respire, 
whereas the parental strain was inhibited. In the presence of nali- 
dixic acid, the Asp87Gly mutant started respiration earlier than the 
Ser83Phe mutant (Figure S2). 
 
Analogous substitutions within gyrase have different 
impacts on quinolone susceptibility and supercoiling 
activity in E. coli and Salmonella 
To determine whether there was a correlation between drug sus- 
ceptibility and supercoiling activity, we purified mutant GyrA pro- 
teins and compared their activities and quinolone susceptibilities 
with that of the WT. We found that gyrase comprising the mutant 
Salmonella proteins  showed  the  expected  levels  of  resistance  
to  ciprofloxacin  (5-fold  increase  in  the   IC50   for  Ser83Phe   and 
10-fold  for  Asp87Gly), and  an  ~3-fold (Ser83Phe)  and ~7-fold 
(Asp87Gly) drop in supercoiling activity compared with the WT en- 
zyme (Table 1). The E. coli mutant enzymes were also tested and 
again showed increases in the ciprofloxacin IC50. The Asp87Gly 
substitution  resulted  in  a  10-fold  increase   (as   seen   with 
the Salmonella enzyme) but the Ser83Phe enzyme showed a 14- 
fold increase, greater than that seen with the Salmonella equiva- 
lent. Interestingly, the relative supercoiling activity of the Ser83Phe 
mutant from E. coli was only reduced by 10%, whereas in 
Salmonella there was a 70% reduction for the equivalent enzyme. 
The increases in the IC50 of ciprofloxacin were reflected in the 
ciprofloxacin MICs for each strain (Table 1). However, the subtle 
changes in enzyme sensitivity seen in these assays were not re- 
flected in changed MIC values between the Ser83Phe and 
Asp87Gly substitutions. In addition, we also made and tested 
Ser83Phe/Asp87Gly double-mutant GyrA proteins; these mutant 
enzymes from both species showed similar low supercoiling activ- 
ity and no detectable inhibition by ciprofloxacin. 
 
Triclosan does not directly interact with DNA gyrase 
in vitro 
One possible explanation for the cross-resistance between quin- 
olones and triclosan in the GyrA mutants is that triclosan is itself an 
inhibitor of DNA gyrase, with gyrase representing a secondary tar- 
get for this drug.5 We tested this possibility using in vitro supercoil- 
ing assays in the presence of triclosan and found no inhibition of 
either Salmonella or E. coli gyrase by triclosan. 
 
Expression of stress response genes is up-regulated in 
Asp87Gly mutants 
The lack of direct interaction of triclosan with DNA gyrase sug- 
gested an indirect mechanism by which gyrA mutation influences 
triclosan susceptibility. To test the hypothesis that gyrA mutations 
altered expression of stress response pathways and thereby sus- 
ceptibility to triclosan we used a set of promoter–gfp reporter 
fusions. 
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Figure 1. Expression of stress response pathways in E. coli strains in drug-free medium. Continuous lines indicate average fluorescence from eight 
replicates (two biological, four technical) of MG1655, dotted lines show data from the Ser83Phe mutant and dashed lines data show from the 
Asp87Gly mutant. Panel (a) shows expression from the recA (SOS) reporter, panel (b) shows expression from the glnA (rpoN) reporter, panel (c) shows 
expression from the gabD (rpoS) reporter and panel (d) shows expression from the opdA (rpoH) reporter. Data are expressed relative to the level of ex- 
pression from the parental strain at the first recording point. 
 
 
When compared with the parental strain, there was elevated 
expression of all four main stress response pathways in the E. coli 
Asp87Gly mutant (Figure 1). However, there was no increase in 
fluorescence seen with the Ser83Phe mutant for any of the four re- 
porters. Up-regulation of all four pathways in the E. coli Asp87Gly 
mutant was seen under all the various stress conditions tested. 
Data from Salmonella showed a different pattern and data 
from whole populations captured in the FluoSTAR showed no sig- 
nificant difference in stress response expression between the gyrA 
mutants and parent. Flow cytometry analysis of GFP expression by 
individual cells did reveal differences between the Salmonella 
strains. The percentage of individual cells within a population ex- 
pressing each reporter gene ranged from ~20% to 25% and did 
not vary greatly between SL1344 or the isogenic gyrA mutant 
strains (Figure 2a). However, when the expression level of GFP was 
measured there were significant differences. There was no 
increased expression of any of the reporters in the Ser83Phe mu- 
tant (Figure 2b). However, in the Asp87Gly mutant there was sig- 
nificantly increased expression of gabD and glnA. Both genes were 
expressed ~66% more than in SL1344 and at more than twice the 
levels seen in the Ser83Phe mutant. 
An Asp87Gly substitution within DNA gyrase of E. coli 
but not Salmonella confers a strong competitive fitness 
benefit in the presence of a low level of triclosan 
Competition experiments were used to test the hypothesis that 
gyrase mutants would show increased fitness in the presence of 
triclosan. A 1:1 ratio of parent and mutant was inoculated and 
then repeatedly passaged for 50 generations in the presence or 
absence of 0.5% the triclosan MIC for  the  parental  strains  
(0.03 mg/L). We chose this concentration in order to see whether a 
concentration of triclosan below that needed to inhibit a WT strain 
would promote expansion of gyrase mutants. 
Both Salmonella mutants were outcompeted by SL1344 in 
drug-free medium. The Ser83Phe mutant was outcompeted by 
SL1344 by the fifth passage (Figure 3). The Asp87Gly mutant was 
also outcompeted by WT, although it never fell below ~5% of the 
population during the experiment. When the experiment with 
these strains was repeated in the presence of triclosan, both mu- 
tants were still outcompeted. Whilst the growth kinetics suggested 
faster growth for the Asp87Gly mutant in this concentration of tri- 
closan, this was not reflected by increased competitive fitness in 
these experiments. 
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Figure 2. Expression of stress response genes in Salmonella gyrase mutants. (a) Percentage of total cells within populations of SL1344 (WT) and iso- 
genic gyrase mutants that were positive for expression of GFP. (b) Average fluorescence of GFP-positive cells. Bars indicate averages of three 
independent replicate cultures; for each, 50000 cells were counted. Values statistically different from the corresponding WT (P , 0.05) are marked by 
an asterisk. 
 
 
In contrast to the Salmonella mutants, the fitness of the E. coli 
mutants was less compromised in the absence of any drug and 
both were maintained throughout the competition experiments. 
As for Salmonella, the Ser83Phe mutant was not fitter in the pres- 
ence of triclosan. However, in the presence of triclosan the 
Asp87Gly E. coli mutant had a dramatic increase in competitive fit- 
ness and strongly outcompeted its parent strain, dominating each 
population from as early as the second passage (Figure 3). 
 
Triclosan exposure does not promote emergence of 
quinolone-resistant mutants 
As the E. coli GyrA Asp87Gly mutant demonstrated a competitive 
fitness benefit in the presence of triclosan, we determined whether 
prolonged triclosan exposure would select for the emergence of 
Asp87Gly mutants from WT cells. To measure this, six independent 
cultures were inoculated and split into LB broth with or without tri- 
closan (0.03 mg/L, as in the competition experiments this selected 
for the Asp87Gly mutant) and passaged repeatedly. After each 
passage the fraction of nalidixic acid-resistant colonies within the 
population was determined in each lineage, and the genotype of 
the QRDR of gyrA determined for 20 of these from each condition. 
Quinolone-resistant mutants were recovered from both lin- 
eages grown in the presence and absence of triclosan  but  
there was no increase in the frequency of nalidixic acid-resistant 
mutants in triclosan-exposed lineages (Figure 4b) compared with 
control lineages (Figure 4a). Interestingly, in both cases nalidixic 
acid-resistant mutants were detected after approximately five 
passages but then decreased by passage nine. DNA sequencing 
and susceptibility testing of a random selection of mutants re- 
covered from nalidixic acid-containing plates confirmed that all 
mutants were quinolone resistant. All mutants had mutations 
within the QRDR of gyrA. The Asp87Gly substitution was recovered 
in lineages passaged in both the presence and absence of triclo- 
san. However, the population of Asp87Gly mutants did not expand 
after first being observed in the triclosan-exposed lineages. The 
Ser83Leu substitution was most commonly recovered in both lin- 
eages, representing the gyrA genotype of 90% of all mutants. 
 
Discussion 
We have previously identified an association in Salmonella be- 
tween resistance to quinolone antibiotics mediated by mutations 
in gyrA and decreased susceptibility to the biocide triclosan.5,33 
Here, we examined two possible mechanisms to explain the asso- 
ciation between gyrA mutation and triclosan resistance: (i) that 
triclosan is itself able to bind gyrase and mutant alleles are insensi- 
tive to inhibition; and (ii) that changed supercoiling activity of mu- 
tant gyrase proteins indirectly influences triclosan susceptibility by 
altering expression of stress response pathways. 
* 
* 
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Figure 3. Competition assays of gyrase mutants versus parental strains in the presence and absence of triclosan. Data show the ratio of parent to 
gyrA mutant strains in competition assays over 6 days grown in drug-free medium (left-hand panels) and in the presence of 0.03 mg/L triclosan 
(right-hand panels). Data are averages from four independent experiments and in each panel the WT is represented by hatched bars and the corres- 
ponding mutant by open bars. Data from Salmonella are in the top four panels and data from E. coli are in the bottom four panels. 
 
Experiments found no evidence for an interaction of triclosan 
with gyrase, which makes the first hypothesis unlikely. Interest- 
ingly, the supercoiling activity of mutant gyrase enzymes with 
substitutions at Ser83 and Asp87 of GyrA differed between   the 
two species. In Salmonella, the Ser83Phe substitution reduced 
the activity of the enzyme to 30% of that of the WT and increased 
the IC50 of ciprofloxacin 5-fold. This is an impact on supercoiling 
activity similar to that previously described for substitution at 
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Figure 4. Emergence of nalidixic acid-resistant mutants in the presence and absence of triclosan. Average frequency of nalidixic acid-resistant mu- 
tants within populations (y-axis) against passage number (x-axis) of MG1655 that were grown in LB broth in the absence (a) or presence (b) of 
0.03 mg/L triclosan. Data shown are average frequencies calculated from six independent lineages in each condition. 
 
Ser83 in E. coli.34 In contrast, the same substitution in E. coli only 
reduced enzyme activity by 10%, but this resulted in a 14-fold in- 
crease in the IC50 of ciprofloxacin. The difference in the altered 
levels of supercoiling activity resulting from the same mutations 
in Salmonella versus E. coli was surprising. The sequence of GyrA 
is highly conserved between the two species, with 92% identity 
and complete conservation of amino acid sequence across the 
enzyme’s active site. There is, however, a difference in codon 
usage between the species within gyrA at the site that encodes 
Ser83—this favours the Ser83Leu substitution in E. coli rather 
than Ser83Phe, which is favoured in Salmonella. We sought here 
to examine the impact of the same gyrA allele in the two species 
so created the Ser83Phe mutation in E. coli. The bigger impact of 
this mutation in E. coli may be influenced by usage of a rare 
codon change. It has been demonstrated that E. coli and Salmo- 
nella maintain a different level of basal supercoiling of chromo- 
somal DNA, suggesting that although GyrA and other 
topoisomerases are conserved between the two species there 
are significant functional differences.26 
We observed a greater reduction in supercoiling activity asso- 
ciated with Asp87Gly mutants in both species; this is again simi- 
lar to other observations in E. coli, although the relative impact 
of the substitution was greater in this study. We used in vitro 
assays whereas the comparator study analysed supercoiling 
changes in vivo, which may account for the difference in degree 
of impact seen.34 The greater change in supercoiling activity in 
Asp87Gly mutants compared with Ser83Phe mutants and   their 
relatively increased ability to grow in the presence of triclosan 
were consistent with our second hypothesis. Analysis of expres- 
sion of four general stress responses in each mutant of both 
species found up-regulation of all four pathways under all condi- 
tions tested in the Asp87Gly mutant of E. coli but not the 
Ser83Phe mutant. In Salmonella there was also a significant dif- 
ference between the two mutants, although this was less 
marked with greater expression of the RpoS and RpoN reporters 
seen in the Asp87Gly mutant. The impact of bacterial stress re- 
sponses in antimicrobial tolerance has been established and 
some recent work has suggested specific impacts on triclosan 
susceptibility.9,35 
Triclosan is now commonly found in the environment, water, 
vegetables and even in people, with concentrations detected in 
urine or plasma ranging from 2.7 to 48 lg/L.18,36 Therefore, as the 
gyrase mutants showed  reduced susceptibility  to triclosan,   we 
sought to examine the impact of triclosan at a subinhibitory con- 
centration on the relative fitness of gyrase mutants compared 
with their parent. In competition assays, for both the Salmonella 
mutants there was a fitness cost, which was evident in both drug- 
free medium and in the presence of low concentrations of triclo- 
san. Under these conditions the benefit of the mutants in the face 
of higher triclosan concentrations was not evident and the WT was 
still fitter in the presence of this concentration of triclosan 
(Figure 3). In contrast to Salmonella, the E. coli Asp87Gly mutant 
could strongly outcompete its parental strain when grown in a low 
concentration of triclosan (Figure 3). 
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To determine whether there was a sufficiently strong selective 
pressure for Asp87Gly mutants to emerge from an E. coli WT popu- 
lation passaged in triclosan, we used an evolution experiment 
(Figure 4). Whilst quinolone-resistant strains (including Asp87Gly 
mutants) did emerge in the experiments, these were not enriched 
by triclosan exposure. However, this experiment only used one tri- 
closan concentration and a relatively short time; longer time peri- 
ods or other selective conditions may give different results. Whilst 
we saw a competitive advantage for the Asp87Gly mutant in our 
competition assays, these were initiated with this strain and the 
parent at a ratio of 50:50. In these evolution experiments the fre- 
quency of emergence of gyrA mutants was ~1%10#8, and it may 
be that a much longer selection is needed to allow these rare mu- 
tants to expand in the population. 
Taken together, the results presented here demonstrate that 
the association between quinolone and triclosan resistance seen 
in both E. coli and Salmonella is not mediated by triclosan interact- 
ing with gyrase. We postulate that the association is mediated by 
up-regulation of stress responses in gyrase mutants as a result of 
altered supercoiling. There was a greater phenotypic impact of 
substitution of Asp87Gly than Ser83Phe in both species tested, but 
a significantly greater impact of this substitution on triclosan sus- 
ceptibility and stress response expression was seen in E. coli com- 
pared with Salmonella. This has implications for the relative fitness 
of different gyrA mutations in different species and suggests some 
gyrA mutants may be ‘primed’ to deal with non-quinolone anti- 
microbial stress exposures. We predicted that this would influence 
the competitive fitness and prevalence of these strains. However, 
our short-term evolution experiment did not show expansion of 
quinolone-resistant mutants from populations exposed to triclo- 
san. Given the increasing prevalence of triclosan and other anti- 
microbials in the environment, a greater understanding of the 
impact they can have on bacteria and how exposure to these non- 
antibiotic antimicrobials may impact the selection and spread of 
clinically relevant antibiotic resistance is needed. 
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